NO143128C - Fremgangsmaate til isolering av hemagglutinin- og neuraminidase-bestanddeler fra et influensavirus - Google Patents

Fremgangsmaate til isolering av hemagglutinin- og neuraminidase-bestanddeler fra et influensavirus

Info

Publication number
NO143128C
NO143128C NO750031A NO750031A NO143128C NO 143128 C NO143128 C NO 143128C NO 750031 A NO750031 A NO 750031A NO 750031 A NO750031 A NO 750031A NO 143128 C NO143128 C NO 143128C
Authority
NO
Norway
Prior art keywords
hemagglutin
neuraminidase
ingredients
insulating
procedure
Prior art date
Application number
NO750031A
Other languages
English (en)
Norwegian (no)
Other versions
NO750031L (ro
NO143128B (no
Inventor
Helmut Bachmayer
Gerhard Schmidt
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO750031L publication Critical patent/NO750031L/no
Publication of NO143128B publication Critical patent/NO143128B/no
Publication of NO143128C publication Critical patent/NO143128C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
NO750031A 1974-01-14 1975-01-06 Fremgangsmaate til isolering av hemagglutinin- og neuraminidase-bestanddeler fra et influensavirus NO143128C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (ro) 1974-01-14 1974-01-14

Publications (3)

Publication Number Publication Date
NO750031L NO750031L (ro) 1975-08-11
NO143128B NO143128B (no) 1980-09-15
NO143128C true NO143128C (no) 1980-12-29

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
NO750031A NO143128C (no) 1974-01-14 1975-01-06 Fremgangsmaate til isolering av hemagglutinin- og neuraminidase-bestanddeler fra et influensavirus

Country Status (27)

Country Link
JP (2) JPS58407B2 (ro)
AT (1) AT345449B (ro)
AU (1) AU500250B2 (ro)
BE (1) BE824372A (ro)
CA (1) CA1049406A (ro)
CH (1) CH589453A5 (ro)
CS (1) CS191254B2 (ro)
DD (1) DD116239A5 (ro)
DE (1) DE2500785B2 (ro)
DK (1) DK140003B (ro)
ES (1) ES433759A1 (ro)
FI (1) FI54053C (ro)
FR (1) FR2257305B1 (ro)
GB (1) GB1498261A (ro)
HK (1) HK56380A (ro)
HU (1) HU173920B (ro)
IE (1) IE40794B1 (ro)
IL (1) IL46426A (ro)
MY (1) MY8100204A (ro)
NL (1) NL166622C (ro)
NO (1) NO143128C (ro)
PH (1) PH14458A (ro)
PL (1) PL93689B1 (ro)
SE (1) SE427238B (ro)
SU (1) SU616997A3 (ro)
YU (1) YU41289B (ro)
ZA (1) ZA75259B (ro)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
NZ567817A (en) * 2005-11-01 2012-01-12 Novartis Vaccines & Diagnostic Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment
AU2008293513B2 (en) * 2007-08-28 2013-11-21 Nanotherapeutics, Inc. Method for producing viral vaccines
WO2015071177A1 (en) 2013-11-15 2015-05-21 Novartis Ag Removal of residual cell culture impurities

Also Published As

Publication number Publication date
IE40794B1 (en) 1979-08-15
HU173920B (hu) 1979-09-28
GB1498261A (en) 1978-01-18
NO750031L (ro) 1975-08-11
SE7500130L (ro) 1975-07-15
NO143128B (no) 1980-09-15
BE824372A (fr) 1975-07-14
ES433759A1 (es) 1977-02-16
PH14458A (en) 1981-07-29
FR2257305B1 (ro) 1982-03-19
MY8100204A (en) 1981-12-31
FR2257305A1 (ro) 1975-08-08
NL166622C (nl) 1981-09-15
PL93689B1 (ro) 1977-06-30
CS191254B2 (en) 1979-06-29
AU500250B2 (en) 1979-05-17
YU41289B (en) 1987-02-28
NL166622B (nl) 1981-04-15
IL46426A (en) 1978-01-31
CH589453A5 (ro) 1977-07-15
FI54053B (fi) 1978-06-30
FI54053C (fi) 1978-10-10
YU5875A (en) 1984-04-30
JPS56127319A (en) 1981-10-06
CA1049406A (en) 1979-02-27
IL46426A0 (en) 1975-04-25
JPS6035326B2 (ja) 1985-08-14
SU616997A3 (ru) 1978-07-25
DK1475A (ro) 1975-09-01
FI750014A (ro) 1975-07-15
NL7500301A (nl) 1975-07-16
JPS50100224A (ro) 1975-08-08
ZA75259B (en) 1976-08-25
DK140003B (da) 1979-06-05
DE2500785A1 (de) 1975-07-31
DE2500785B2 (de) 1980-01-03
AT345449B (de) 1978-09-11
IE40794L (en) 1975-07-14
ATA21475A (de) 1978-01-15
DE2500785C3 (ro) 1980-09-11
AU7730575A (en) 1976-07-15
DK140003C (ro) 1979-10-29
HK56380A (en) 1980-10-16
DD116239A5 (ro) 1975-11-12
JPS58407B2 (ja) 1983-01-06
SE427238B (sv) 1983-03-21

Similar Documents

Publication Publication Date Title
NO141385C (no) Fremgangsmaate for forvaesking av jordgass
NO143028C (no) Fremgangsmaate til fremstilling av n-holdige kondensasjonsprodukter
SE7511188L (sv) Forbettringar av eller avseende luftelektroder
SE7505955L (sv) Tverbindningsforfarande
NO143429C (no) Fremgangsmaate til fremstilling av n-holdige kondensasjonsprodukter
SE7803860L (sv) Forfarande for framstellning av 7-d-(-)-alfa-amino-alfa(p-hydroxifenylacetamido)desacetoxicefalosporansyra
DK136398C (da) Fremgangsmaade til fremstilling af et analgetisk-antipyretisk praeparat
SE7505101L (sv) Forfarande for framstellning av emulgeringssystem.
SE7811635L (sv) Forfarande for framstellning av 7 -acylamino-7 -alkoxicefalosporiner eller 6 -acylamino-6 -alkoxipenicilliner
NO143128C (no) Fremgangsmaate til isolering av hemagglutinin- og neuraminidase-bestanddeler fra et influensavirus
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
NO143559C (no) Fremgangsmaate for fremstilling av proteiner fra poteter
SE431207B (sv) Forfarande for framstellning av tiazolidinderivat
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
NL179698B (nl) Gas- en/of dampontladingsstraler.
IT1051024B (it) Ureidocomposti sostituiti e procedimento per la loro preparazione
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
DK143556C (da) Analogifremgangsmaade til fremstilling af substituerede phenylisothiourinstoffer
SE7513879L (sv) Forfarande for syntes av karbamider
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
TR18624A (tr) Oktennitril bilesimlerinin hazirlanmasi usul ve bu usulle elde edilmis bilesimler
NO152937C (no) Fremgangsmaate til fremstilling av et attenuert panelukopeni-virus.
SE7508654L (sv) Forfarande for framstellning av steroider
SE418395B (sv) Forfarande for framstellning av indanettiksyror
NO142711C (no) Fremgangsmaate ved fremstilling av dinitriler fra thiodinitriler